Gingivectomy or Gingivoplasty — One to Three Contiguous Teeth or Tooth-Bounded Spaces per Quadrant Template

Gingivectomy/gingivoplasty - one to three contiguous teeth per quadrant.

RMH: Medical history reviewed/updates
Vitals: BP/pulse; other vitals if indicated

Quadrant: Quadrant
Teeth: #Tooth number(s)
Indication: Indication/diagnosis

Consent: Consent/PARQ reviewed; signed/verbally obtained

Periodontal chart/radiographs: Probing/BOP/CAL and radiographs/photos as applicable

Anesthesia: Anesthetic used
Carps: Carpules/amount

Periodontal surgery support: Area/teeth/sites involved and reason procedure is indicated
Pre-op periodontal documentation: Probing, BOP, CAL, recession, furcation, mobility, radiographic bone loss
Surgical access/closure: Flap/access, osseous/soft tissue changes, materials, closure

Procedure:
Bleeding points marked.
Tissue excised with: Tissue excised with
Tissue contoured.
Hemostasis achieved.
Periodontal dressing placed: Periodontal dressing placed

Complications: None or describe.

Patient tolerance: Tolerance/response.

Post-op instructions: Instructions reviewed.
Rx: Prescription or none

NV: Next visit

Documentation requirements

Periodontal surgery notes are reviewed harder than almost any other category — partly because the codes are surgical-fee, partly because the line between D4211, D4212, D4249, and D4341/D4342 lives entirely in the chart. Per the AAP best-evidence consensus on periodontal surgery, 's periodontics chapter (pp. 105-112), and the Aetna / Anthem / HDS clinical policy bulletins, a defensible D4211 note must contain:

• Quadrant and tooth identification — UR / UL / LR / LL plus universal numbers of every tooth (or tooth-bounded space) in the surgical field. Confirm the count is 1-3 and contiguous. If non-contiguous, document the rationale and the split-claim plan up front.
• Indication / diagnosis — the specific clinical reason: drug-induced gingival overgrowth (name the medication), idiopathic or hereditary gingival fibromatosis, localized inflammatory hyperplasia, orthodontic-associated overgrowth, mouth-breathing hypertrophy, localized esthetic recontour, suprabony pseudopocket elimination, or pre-prosthetic marginal reshaping prior to a planned crown impression. Avoid generic "tissue overgrowth" — carriers reject vague indications.
• Medical and dental history — reviewed today; flag medications causing gingival overgrowth (cyclosporine, calcium-channel blockers, phenytoin), anticoagulants (impacts hemostasis), bisphosphonates / anti-resorptives, immunosuppression, smoking status, diabetes (HbA1c if known — surgical healing risk factor), and history of prior periodontal surgery in the area.
• Vital signs — pre-op BP and pulse; post-op vitals when sedation, anxious patient, or hypertensive history.
• Pre-op periodontal charting — site-specific probing depths (six sites per tooth), bleeding on probing (BOP), clinical attachment level (CAL), recession, furcation involvement (Glickman / Hamp), mobility (Miller class), suppuration, and keratinized / attached gingiva width. Probing depths of at least 5 mm at the surgical sites are the typical carrier threshold — document the actual numbers, per tooth, per site. "Deep pockets" without numbers is not defensible.
• Radiographic findings — interpretation of recent PA(s) and bitewings: bone levels relative to the CEJ, presence or absence of crestal bone loss, lamina dura. The point is to affirm bone is healthy at the surgical sites — D4211 by definition addresses suprabony tissue, not bone. If bone loss is present at the sites, the case is more likely D4240/D4241 or D4260/D4261, and that decision belongs in the chart.
• Pre-op intraoral photographs — strongly recommended (and required by several carriers including Anthem clinical policy and many Medicaid MCOs). Photographs document the tissue contour, hyperplasia, or restorative-access scenario in a way that probing numbers alone do not.
• Differential ruling out D4249 — explicit statement that bone removal is not indicated because biologic width is intact, ferrule is achievable on tooth structure coronal to the alveolar crest, and the case is soft-tissue only. This is the single most important differential to put in writing when a crown is planned on the same tooth.
• Differential ruling out D4212 — when the indication is hyperplasia or pseudopocket elimination (not restorative access), state it plainly. Aetna and several Medicaid MCOs alternate-benefit D4211 to D4212 when the chart reads as a restorative-access case.
• Informed consent / PARQ — risks specific to gingivectomy: post-op bleeding, swelling, sensitivity, recurrence (especially with continued causative medication), gingival recession, root sensitivity, slow healing in smokers / diabetics, mucogingival problem if too much keratinized tissue removed, alternative of medication change (in collaboration with prescribing physician) for drug-induced overgrowth, no-treatment risks (continued inflammation, plaque retention, periodontal progression). Note signed vs verbal.
• Anesthesia — agent, concentration, vasoconstrictor, technique, and carpule count. Hemostasis matters in gingivectomy; epinephrine-containing local helps the surgical field.
• Bleeding points marked — explicit step. The classic Goldman-Cohen gingivectomy technique marks the base of the pocket externally with a pocket marker so the incision contour follows the actual sulcus depth.
• Excision instrument(s) — Kirkland knife / Orban knife / 15c blade / electrosurgery / diode laser / Er:YAG laser / Nd:YAG laser. Lasers (especially diode and Er:YAG) are increasingly common; document the wavelength and settings if used. The instrument choice matters for healing characterization and for potential payer questions about whether a "true gingivectomy" was performed.
• Tissue contouring / gingivoplasty step — explicit reshaping to a physiologic, festooned contour. The ADA descriptor pairs gingivectomy with gingivoplasty; chart both steps.
• Hemostasis — pressure, electrocautery, hemostatic agent (aluminum chloride, ferric sulfate, gelfoam, Surgicel). Note achieved status.
• Periodontal dressing — non-eugenol dressing (Coe-Pak, Barricaid) placed or not placed. Many gingivectomies on small fields heal well without dressing; document the decision either way.
• Tissue submitted for biopsy — when any aspect of the excised tissue is atypical, send to pathology and document (separate code D7286 for the biopsy plus D0472/D0473/D0474 for the histopathology read by the pathologist).
• Attached gingiva remaining — confirm at least 3 mm of attached keratinized tissue remains apical to the new gingival margin. This is the mucogingival safeguard cited in AAP guidance.
• Complications — explicit "None" or describe (excessive bleeding, exposure of bone, exposure of root surface beyond expected, soft-tissue injury).
• Patient tolerance / response — tolerated well, mild discomfort managed, no adverse events.
• Post-op instructions — soft diet for 7-10 days, no rinsing for 24 hours, chlorhexidine 0.12% rinse BID after first 24 hours for 1-2 weeks, careful brushing around site, ice for swelling first 24 hours, NSAID regimen, return precautions for bleeding / swelling / fever, smoking cessation counseling if applicable.
• Prescriptions — analgesics (commonly ibuprofen 600 mg q6h prn), chlorhexidine 0.12% rinse, antibiotics only when clinically indicated (immunocompromise, large surgical field, systemic involvement).
• Crown-impression timing (when relevant) — if the procedure was done to recontour gingiva prior to a crown impression on the same tooth, explicitly schedule the impression at least 4-6 weeks out. Aetna's policy is "minimum of four to six weeks prior to final preparation/impressions to be considered for benefits." Same-day or one-week impressions invalidate the surgical fee on most policies.
• Causative-medication management referral (drug-induced overgrowth) — the single most defensible chart note for cyclosporine, amlodipine/nifedipine, or phenytoin overgrowth includes a note that the patient was referred back to the prescribing physician for medication review, because the overgrowth will recur otherwise. Documents that the surgery is the right step, not the only step.
• Next visit — post-op check at 7-14 days; periodontal re-evaluation at 4-6 weeks to verify healing and final tissue contour; subsequent crown impression appointment if applicable.
• Provider signature and assistant initials.

Two phrases that defuse the most common audit questions: "1-3 contiguous teeth in [quadrant]; teeth #X-#Y; soft-tissue only, no bone removed" and "pre-op probing depths >=5 mm at involved sites; pre-op photos and periodontal chart on file." Both track the descriptor language and the carrier policy thresholds directly.

Common denial reasons

D4211 sits at the intersection of three carrier review patterns — contiguity / tooth-count rules, soft-vs-hard-tissue alternate benefits, and same-day bundling. The most frequent reasons it is denied, downgraded, or recouped:

• Non-contiguous teeth on a single D4211 line — chart shows surgery on, e.g., #6 and #8 with healthy #7 between. Most carriers will not pay D4211 across non-adjacent teeth on one line.
• Tooth count > 3 — when the operative report describes surgery on 4+ teeth and the claim was D4211, the auto-edit flips to D4210 and a question is raised about the original code. Re-billing as D4210 is the correct fix.
• Down-code to D4212 — chart indication reads as restorative access on 1-3 teeth (deep margin, caries extension, crown prep) instead of true hyperplasia or pseudopocket elimination. Aetna and several Medicaid MCOs alternate-benefit to D4212 routinely.
• Down-code to D4341/D4342 — chart describes scaling and tissue management without true tissue excision and contour change; reviewer concludes the procedure was non-surgical SRP.
• Same-day bundling with SRP (D4341/D4342) — D4211 performed in the same anatomical area on the same DOS as scaling and root planing. Aetna/Anthem/HDS policy bulletins explicitly bundle these.
• Same-day bundling with D4274 (distal wedge) in the same anatomical area.
• Same-day bundling with D7960 (frenectomy) in the same anatomical area.
• Same-day bundling with crown prep on the same tooth — soft-tissue trimming considered inclusive to the crown procedure.
• Same-day bundling with extraction (D7140 / D7210) in the same quadrant when the gingival contour was incidental to the extraction site.
• Pocket depths < 5 mm at the surgical sites — when the indication is pseudopocket elimination but the chart shows probing depths under threshold, carriers deny on medical-necessity grounds.
• No pre-op periodontal chart — chart describes "deep pockets" without site-specific numbers. Carrier reviewers cannot validate medical necessity from prose.
• No pre-op photographs — Anthem clinical policy and several Medicaid MCOs require pre-op intraoral photos for hyperplasia / drug-induced overgrowth / esthetic indications. Missing photos = denial.
• D4211 billed as soft-tissue crown lengthening (D4249) — chart describes soft-tissue-only excision; carrier down-codes D4249 to D4211 (or to D4212), or denies D4249 outright. "Soft tissue crown lengthening will not be benefited as D4249" is verbatim language in several carrier policies.
• D4249 narrative submitted for D4211 — operative report describes flap reflection and bone removal but billed under D4211; unusual but seen, and corrected to D4249 on review.
• Frequency exceeded — second D4211 in the same quadrant within 36 months without a clear new indication. A repeat for recurrent drug-induced overgrowth on the same medication can be defensible with a narrative documenting the medication has not been changed despite consult; without that narrative, denied.
• Esthetic-only indication on a medical-only plan — many plans exclude purely cosmetic gingival recontour. Pre-D with a clear functional indication (plaque retention, hygiene access, asymmetry interfering with function) is the correct workflow when esthetics is the chief patient concern.
• Crown impression taken too soon after gingivectomy — when D4211 is billed on a tooth and the crown impression is taken within days or 1-2 weeks, downstream crown coverage may be challenged because tissue position is unstable. Aetna's 4-6 week minimum is the typical benchmark.
• Default-template chart notes — identical procedure language across multiple patients flagged as templating during MCO and commercial automated audits. The same descriptive sentence on every gingivectomy is a fingerprint.
• Missing differential against D4249 — chart silent on whether bone removal was considered. Reviewers infer the case may have warranted D4249 (lower or higher fee depending on policy) and request more documentation.
• No medication-management note for drug-induced overgrowth — surgery without a referral back to the prescribing physician is sometimes flagged as incomplete management; recurrence is predictable and the chart should reflect that the patient was counseled.
• Antibiotic prescription with no systemic involvement — flagged on chart audits even though it doesn't directly affect D4211 reimbursement. AAP and ADA stewardship guidance is explicit: routine antibiotics for localized soft-tissue periodontal surgery in healthy patients are not indicated.

Related templates